European Medical Solutions (ALEMS.BR)

EUR 5.0

(3.08%)

EBITDA Summary of European Medical Solutions

European Medical Solutions's latest annual EBITDA in 2023 was 59 Thousand EUR , down -97.46% from previous year.
European Medical Solutions's latest quarterly EBITDA in 2023 FY was N/A , down -97.46% from previous quarter.
European Medical Solutions reported an annual EBITDA of -1.25 Million EUR in 2022, up 13.12% from previous year.
European Medical Solutions reported an annual EBITDA of 2.05 Million EUR in 2021, up 498.51% from previous year.
European Medical Solutions reported a quarterly EBITDA of N/A for 2023 FY, down -97.46% from previous quarter.
European Medical Solutions reported a quarterly EBITDA of -983 Thousand EUR for 2023 Q4, down -194.34% from previous quarter.

Annual EBITDA Chart of European Medical Solutions (2023 - 2013)

Historical Annual EBITDA of European Medical Solutions (2023 - 2013)

Year	EBITDA	EBITDA Growth
2023	59 Thousand EUR	-97.46%
2022	-1.25 Million EUR	13.12%
2021	2.05 Million EUR	498.51%
2020	-514.66 Thousand EUR	96.71%
2019	- EUR	-25.1%
2018	-12.51 Million EUR	-6.32%
2017	-11.77 Million EUR	3.02%
2016	-12.13 Million EUR	-60.54%
2015	-7.53 Million EUR	-75.9%
2014	-4.29 Million EUR	-88.84%
2013	-2.26 Million EUR	0.0%

Year	EBITDA	EBITDA Growth
2023 Q2	1.04 Million EUR	56.69%
2023 FY	- EUR	-97.46%
2023 Q4	-983 Thousand EUR	-194.34%
2022 Q4	665 Thousand EUR	-59.82%
2022 FY	- EUR	13.12%
2022 Q2	1.65 Million EUR	-61.28%
2021 FY	- EUR	498.51%
2021 Q4	4.27 Million EUR	1221.99%
2021 Q2	-381 Thousand EUR	-185.55%
2020 Q2	-960 Thousand EUR	88.02%
2020 FY	- EUR	96.71%
2020 Q4	445.33 Thousand EUR	146.39%
2019 Q4	-8.01 Million EUR	-4.85%
2019 FY	- EUR	-25.1%
2019 Q2	-7.64 Million EUR	-5.09%
2018 Q4	-7.27 Million EUR	-38.73%
2018 FY	- EUR	-6.32%
2018 Q2	-5.24 Million EUR	-3.86%
2017 Q2	-6.72 Million EUR	-40.03%
2017 Q4	-5.04 Million EUR	24.93%
2017 FY	- EUR	3.02%
2016 Q2	-7.33 Million EUR	-66.8%
2016 FY	- EUR	-60.54%
2016 Q4	-4.8 Million EUR	34.56%
2015 Q2	-3.16 Million EUR	0.0%
2015 Q4	-4.39 Million EUR	-39.09%
2015 FY	- EUR	-75.9%
2014 FY	- EUR	-88.84%
2013 FY	- EUR	0.0%

Peer EBITDA Comparison of European Medical Solutions

Name	EBITDA	EBITDA Difference
Nicox S.A.	-16.23 Million EUR	100.363%
FERMENTALG	-10.51 Million EUR	100.561%
argenx SE	-199.5 Million EUR	100.03%
BioSenic S.A.	-6.79 Million EUR	100.868%
Celyad Oncology SA	-7.76 Million EUR	100.76%
Hyloris Pharmaceuticals SA	-14.98 Million EUR	100.394%
Onward Medical N.V.	-35.23 Million EUR	100.167%
Oxurion NV	-16.72 Million EUR	100.353%
PHAXIAM Therapeutics S.A.	-22.93 Million EUR	100.257%
Financière de Tubize SA	184.57 Thousand EUR	68.034%
UCB SA	1.26 Billion EUR	99.995%